Literature DB >> 16386271

Native spliceosomes assemble with pre-mRNA to form supraspliceosomes.

Maia Azubel1, Naomi Habib, Ruth Sperling, Joseph Sperling.   

Abstract

Regulation of eukaryotic gene expression is achieved at different levels, which require accurate coordination. Macromolecular assemblies that exist as pre-formed entities can account for such coordination. Processing of pre-mRNA represents one step in this cascade of regulatory events but, moreover, provides explanation for protein versatility. The cellular machine where splicing of pre-mRNA, as well as additional processing events, take place in vivo is termed the supraspliceosome. Here, we show that the supraspliceosome is composed of four active spliceosomes, termed native spliceosomes, connected to each other by the pre-mRNA. Cleavage of pre-mRNA shows that its integrity is essential for the stability of the supraspliceosome. Furthermore, supraspliceosomes can be reconstituted in vitro, from purified native spliceosomes by addition of synthetic pre-mRNAs, providing further support to the supraspliceosome as a preassembled biological complex. The internal setting of the native spliceosomes within the supraspliceosome is most suitable to enable the communication between these structures, which is crucial in order to achieve regulated splicing.

Mesh:

Substances:

Year:  2005        PMID: 16386271     DOI: 10.1016/j.jmb.2005.11.078

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  25 in total

1.  A potential role for initiator-tRNA in pre-mRNA splicing regulation.

Authors:  Eyal Kamhi; Oleg Raitskin; Ruth Sperling; Joseph Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Intranuclear binding kinetics and mobility of single native U1 snRNP particles in living cells.

Authors:  David Grünwald; Beatrice Spottke; Volker Buschmann; Ulrich Kubitscheck
Journal:  Mol Biol Cell       Date:  2006-09-20       Impact factor: 4.138

3.  The cell nucleus taking centre stage. Workshop on the functional organization of the cell nucleus.

Authors:  Yosef Gruenbaum; Ivan Raska; Harald Herrmann
Journal:  EMBO Rep       Date:  2006-10-27       Impact factor: 8.807

Review 4.  Connecting the dots: chromatin and alternative splicing in EMT.

Authors:  Jessica A Warns; James R Davie; Archana Dhasarathy
Journal:  Biochem Cell Biol       Date:  2015-07-07       Impact factor: 3.626

5.  Dual function of C/D box small nucleolar RNAs in rRNA modification and alternative pre-mRNA splicing.

Authors:  Marina Falaleeva; Amadis Pages; Zaneta Matuszek; Sana Hidmi; Lily Agranat-Tamir; Konstantin Korotkov; Yuval Nevo; Eduardo Eyras; Ruth Sperling; Stefan Stamm
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-08       Impact factor: 11.205

6.  A novel tissue-specific alternatively spliced form of the A-to-I RNA editing enzyme ADAR2.

Authors:  Lily Agranat; Joseph Sperling; Ruth Sperling
Journal:  RNA Biol       Date:  2010-03-17       Impact factor: 4.652

7.  Regulation of alternative splicing within the supraspliceosome.

Authors:  Naama Sebbag-Sznajder; Oleg Raitskin; Minna Angenitzki; Taka-Aki Sato; Joseph Sperling; Ruth Sperling
Journal:  J Struct Biol       Date:  2011-11-12       Impact factor: 2.867

8.  The differential interaction of snRNPs with pre-mRNA reveals splicing kinetics in living cells.

Authors:  Martina Huranová; Ivan Ivani; Ales Benda; Ina Poser; Yehuda Brody; Martin Hof; Yaron Shav-Tal; Karla M Neugebauer; David Stanek
Journal:  J Cell Biol       Date:  2010-10-04       Impact factor: 10.539

9.  Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA.

Authors:  Bettina Heinrich; Zhaiyi Zhang; Oleg Raitskin; Michael Hiller; Natalya Benderska; Annette M Hartmann; Laurent Bracco; David Elliott; Shani Ben-Ari; Hermona Soreq; Joseph Sperling; Ruth Sperling; Stefan Stamm
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

Review 10.  Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.

Authors:  Maxime Blijlevens; Jing Li; Victor W van Beusechem
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.